Gadolinium-based contrast agents (GBCAs) are the only approved class of drugs for use with MRI in the United States. There has been increasing concern among radiologists about potential legal exposure from its use. Several patients have come forward reporting adverse
Have you ever wondered if your patient volumes are high or low? Would it be helpful to know where your department stands relative to other hospitals across the country? Now, with the new Patient Volume Benchmark Report, you can know.
Precision radiopharmaceutical diagnostic imaging procedures help identify abnormalities early in the progress of a disease —before many medical problems are apparent with other diagnostic tests. Despite the proven effectiveness of radiopharmaceuticals, such as Axumin and NETSPOT, countless patients are limited
This post was written by John W. Mitchell and first appeared on DOTmed HealthCare Business Daily News. It has been reposted here with permission of the publisher. Two sources report that they are responding to rapidly changing demands of their
The entire medical system of the United States has been focused on a single threat over the past eight weeks. While the dangers from COVID-19 remain present, many states are beginning to open back up, and as capacity increases, medical
While the majority of the current COVID-19 related news pertains to the care and treatment of patients with confirmed coronavirus cases, there is emerging data about the complications that can arise after a patient recovers from the virus. New JAMA
CONNECT WITH DMS
©2020 DMS Health Technologies
